Newsfeed:
- Man ‘bullied’ into attending benefits appointment days after brain surgery – The IndependentMan 'bullied' into attending benefits appointment days after brain surgery The Independent ... read more
- New full-service neurology clinic now open in Moscow – Moscow-Pullman Daily NewsNew full-service neurology clinic now open in Moscow Moscow-Pullman Daily News ... read more
- What It’s Like Knowing My Parkinson’s Is Getting Worse – Yahoo LifestyleWhat It's Like Knowing My Parkinson's Is Getting Worse Yahoo Lifestyle ... read more
- Rosacea, breast cancer possibly linked – Dermatology TimesRosacea, breast cancer possibly linked Dermatology Times ... read more
- ‘Scratching the surface’: the aged care stories that go untold may be the worst – The Guardian
- LIGHT OF DAY WINTERFEST Celebrates 20th Anniversary – Broadway WorldLIGHT OF DAY WINTERFEST Celebrates 20th Anniversary Broadway World ... read more
- Axial Biotherapeutics Presents Preclinical Data on Microbiome-Derived Metabolites Associated with Autism Spectrum Disorder at the Society for Neuroscience 2019 Annual Meeting – BioSpace
- New NIH BRAIN Initiative awards accelerate neuroscience discoveries – EurekAlert
- New NIH BRAIN Initiative awards accelerate neuroscience discoveries – National Institutes of HealthNew NIH BRAIN Initiative awards accelerate neuroscience discoveries National Institutes of Health ... read more
- Runner With Parkinson’s Bangs Out 351 Burpees on Way to Finishing Chicago Marathon – Runner’s World
- Nuvectra Submits Chemical Composition and Biocompatibility Data to FDA for Virtis – BioSpace
- Comedian Billy Connolly may never be able to perform again due to Parkison’s disease – Mirror Online
- Stool Calprotectin May Be Used as Marker of Bowel Inflammation in Parkinson’s Patients, Study Finds
The levels of calprotectin — a protein whose levels increase in response to tissue inflammation — in the stool may be used as a marker of bowel inflammation in patients with Parkinson’s disease, according to a recent study. The results, “Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson’s Disease,” were published in Frontiers in ... read more - Istradefylline Now Available for Patients With Parkinson Disease Experiencing “Off” EpisodesNourianz (istradefylline; Kyowa Kirin) is now available as an adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson disease (PD) experiencing “off” episodes. The approval of Nourianz, an adenosine A2A receptor antagonist, was based on results from 4 randomized, placebo-controlled clinical trials involving a total of 1143 PD patients who were taking a stable dose of levodopa/carbidopa with or without ... read more
- Parkinson’s Foundation Opens Campaign to Support Newly DiagnosedTo provide new patients with the information, tools and resources they need to best manage their health, the Parkinson’s Foundation has launched a campaign to close the gap between learning of an illness and knowing how and where to find help. Called “Newly Diagnosed: Building a Better Life with Parkinson’s Disease,” the effort is said to be the first such national ... read more
- Neuroscientists to introduce new approach to assess brain damage in Parkinson’s patientsTSU neuroscientists and their colleagues from SibSMU plan to introduce a new approach to studying brain damage in patients with Parkinson's disease ... read more
- Plasma NfL Levels Offer Potential for Predicting Parkinson Disease Severity and ProgressionElevated plasma neurofilament light chain (NfL) levels are associated with higher disease severity and dementia in patients with Parkinson disease (PD), a study in Neurology suggests. Patients with PD (n=116), multiple system atrophy (MSA [n=22]), and healthy controls (n=40) were enrolled in this prospective follow-up study. An electrochemiluminescence immunoassay was used to measure participants’ plasma NfL levels. At baseline and ... read more
- Sunderland couple’s joint battle with Parkinson’s disease is turned into a film – Sunderland Echo
- Parkinson’s Disease Drug Market Insights and Global Outlook During 2019-2025Oct 18, 2019 (Market Insight Reports via COMTEX) -- The Parkinson's Disease Drug Marketrecently Published Global Market research study with more than 100industry informative desk and Figures spread ... read more
- Does bipolar disorder increase the risk of Parkinson’s disease?A review published by the JAMA Network has found that the risk of Parkinson's disease is significantly higher in those with bipolar disorder. ... read more
- Homepage Round-Up: Women Have Less Twitter Influence than Men in Health Care, Bipolar Disorder Linked to Parkinson’s Disease, and More – DocWire News
- Global Parkinson’s Disease Treatments Market 2019-2025 by Companies GSK, Merck, Novartis, Teva – Galus Australis
- Parkinson’s: New treatment approach shows promise in brain cells – Medical News TodayParkinson's: New treatment approach shows promise in brain cells Medical News Today ... read more
- Farmer’s book documenting a life on the land raises £6,000 for Parkinson’s charityBut he was forced to retire after being diagnosed with Parkinson's disease in 2006. He said his book, named A Life in Farming, aimed to raise money for the charity which helped him deal with the ... read more
- Parkinson’s disease Drug Market 2019: Presents Huge Growth Opportunity changing market trends, new business opportunities analysis and forecast 2025 – Market Expert
